Recurrent neural network-based model predictive control for continuous pharmaceutical manufacturing (Q1634707): Difference between revisions

From MaRDI portal
Import240304020342 (talk | contribs)
Set profile property.
Created claim: Wikidata QID (P12): Q128954910, #quickstatements; #temporary_batch_1724703925167
 
(3 intermediate revisions by 3 users not shown)
Property / OpenAlex ID
 
Property / OpenAlex ID: W2883194111 / rank
 
Normal rank
Property / arXiv ID
 
Property / arXiv ID: 1807.09556 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Advanced control of industrial processes. Structures and algorithms. / rank
 
Normal rank
Property / Wikidata QID
 
Property / Wikidata QID: Q128954910 / rank
 
Normal rank

Latest revision as of 21:32, 26 August 2024

scientific article
Language Label Description Also known as
English
Recurrent neural network-based model predictive control for continuous pharmaceutical manufacturing
scientific article

    Statements

    Recurrent neural network-based model predictive control for continuous pharmaceutical manufacturing (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    18 December 2018
    0 references
    Summary: The pharmaceutical industry has witnessed exponential growth in transforming operations towards continuous manufacturing to increase profitability, reduce waste and extend product ranges. Model Predictive Control (MPC) can be applied to enable this vision by providing superior regulation of Critical Quality Attributes (CQAs). For MPC, obtaining a workable system model is of fundamental importance, especially if complex process dynamics and reaction kinetics are present. Whilst physics-based models are desirable, obtaining models that are effective and fit-for-purpose may not always be practical, and industries have often relied on data-driven approaches for system identification instead. In this work, we demonstrate the applicability of Recurrent Neural Networks (RNNs) in MPC applications in continuous pharmaceutical manufacturing. RNNs were shown to be especially well-suited for modeling dynamical systems due to their mathematical structure, and their use in system identification has enabled satisfactory closed-loop performance for MPC of a complex reaction in a single Continuous-Stirred Tank Reactor (CSTR) for pharmaceutical manufacturing.
    0 references
    pharmaceuticals
    0 references
    critical quality attributes (CQAs)
    0 references
    recurrent neural networks
    0 references
    model predictive control (MPC)
    0 references
    system identification
    0 references

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references